Clinical Data acquires Genaissance for $55mm
To bring itself into the field of pharmacogenomics, diagnostic instrumentation company Clinical Data has acquired Genaissance Pharmaceuticals for approximately $46mm in stock plus the assumption of about $9mm in debt.
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
Drug Discovery Tools
- Full Acquisition
- Includes Contract
- Intra-Biotech Deal
- Payment Includes Stock
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.